RADIO PHARMACEUTICAL PROCEDURE PROTOCOL: QUADRAMET
|
|
- Stephany Bradley
- 8 years ago
- Views:
Transcription
1 RADIO PHARMACEUTICAL PROCEDURE PROTOCOL: QUADRAMET (Sm- 153 lexidronam EDTMP) for metatstatic bone pain PRODUCT OVERVIEW: Samarium (Sm- 153) Lexidronam (Quadramet ) Quadramet is a radiopharmaceutical consisting of stable complexes of radioactive Samarium (Sm- 153) and tetraphosphonate chelators (EDTMP). Sm- 153 has a half life of 46.3 hours and emits both beta and gamma radiation. The gamma radiation can be used to follow the uptake of the radionuclide in vivo, whereas the beta radiation provides the therapeutic effect? of the compound. Quadramet has a high affinity to the skeleton and concentrates after intravenous injection in areas of elevated bone turnover (osteoblastic lesions). It is indicated as a palliative measure for the relief of pain from metastatic lesions that enhance on bone scans. The onset of pain relief observed with Quadramet is rapid, about one week after injection. Health Canada approved Quadramet for palliation of bone pain. For additional information regarding this agent, consult package insert or other standard references including consensus treatment guidelines recommending Quadramet (EANM, SNM, Cancer Care Ontario, ASCO.) TARGET PATIENT POPULATION Patients with pain secondary to cancer metastatic to bones with activity demonstrated on bone scan. Osteosarcoma patients are treated under a different protocol. Patients must have had a CBC/platelet count within the past 7 days. The results must be verified by the staffing nuclear medicine physician. 1
2 RADIO PHARMACEUTICAL PROCEDURE PROTOCOL: QUADRAMET (Sm- 153 lexidronam EDTMP) for metatstatic bone pain CONTENTS OF QUADRAMET (Sm- 153 lexidronam EDTMP) Procedure Protocol AUTHORIZATION SCHEDULING PROCESS PROCUCT PROCUREMENT GENERAL PREPARATION DOSE PREPARATION PATIENT PREPARATION PREPARATION OF INPATIENT TREATMENT ROOM ADMINISTRATION OF DOSE DOSE MEASUREMENTS INPATIENT DISCHARGE PROTOCOL OUTPATIENT TREATMENT AND RELEASE 2
3 RADIO PHARMACEUTICAL PROCEDURE PROTOCOL: QUADRAMET (Sm- 153 lexidronam EDTMP) for metatstatic bone pain INSTRUCTIONS/GUIDELINES FOR PATIENT AUTHORIZATION AND TREATMENT DIRECTIVE The treating physician (Radiation Oncologist, Medical Oncologist, Hematologist or Nuclear Medicine Physician) who is authorized to make a treatment decision will determine if Quadramet is appropriate therapy based on treatment guidelines and clinical assessment. A written directive will be given to initiate product procurement and preparations of the patient and the facility. SCHEDULING PROCESS 1. Clinic schedulers will contact the Nuclear Medicine scheduling staff with a request for a Samarium- 153 therapy. 2. The Nuclear Medicine schedulers will record information on a Nuclear Medicine Scheduling Sheet, deliver it to the Lead Nuclear Medicine Technologists Work room and notify the Lead Nuclear Medicine Technologist that the form is there. 3. Upon receipt of the Nuclear Medicine Scheduling Sheet, the Lead Nuclear Medicine Technologist will attach the written Directive and deliver to Nuclear Medicine Staff Physician for approval. 4. After approval, the Nuclear Pharmacy is contacted to check availability of drug. 5. The Lead Nuclear Medicine Technologist will then contact a Lead Scheduler to schedule the therapy. 6. The ordering clinic will then be contacted with the date and time. PRODUCT PROCUREMENT 1. Upon receipt of the written directive, the radiopharmacy will contact Superna Life Sciences/Lantheus Medical Imaging to arrange for product delivery. Sm- 153 EDTMP is ordered as a frozen, pre- calibrated intravenous bulk dose. 2. A minimum lead time of 72 hours is required. 3. The Radiopharmacy will order via phone with confirmation of the order returned by fax or e- mail. A time estimate of arrival of product will be communicated to the authorizing physician. 4. The Quadramet vial is calibrated for Wednesday, 12:00 noon, ET, and expires Friday, 8:00 PM ET, or 8 hours from thawing, whichever comes first. 5. Quadramet will be shipped via FedEx or other expedited commercial carrier. GENERAL PREP 1. Check the product identification tag attached to the vial to ensure accurate identification of the product and dose. 2. The Sm- 153 EDTMP product data and lot numbers are logged in the radiopharmacy computer and listed in the index of products. NM radiopharmacy labels are to be affixed to the lead pot. 3
4 RADIO PHARMACEUTICAL PROCEDURE PROTOCOL: QUADRAMET (Sm- 153 lexidronam EDTMP) for metatstatic bone pain 3. The technologist preparing the dose and the nuclear medicine physician administering the dose must wear gloves, a lab coat, a TLD, and a ring badge and adhere to good radiation safety practice. DOSE PREP 1. The patient s dose of Sm- 153 EDTMP is calculated using the following weight based calculation 1mCi x (patient weight in kilograms) and will be prescribed by a nuclear medicine physician 2. The Sm- 153 EDTMP product data and lot numbers are logged in the radiopharmacy computer and listed in the index of products. The computer is used to calculate the volume of Sm- 153 EDTMP for the prescribed dose. The contents of the vial and all product information must be verified prior to withdrawing the dose. 3. Initial preparation of the drug requires thawing. Quadramet must be used within 8 hours of thawing. 4. The dose is prepared in the [ENTER LOCATION for example, Radiopharmacy Laboratory] with work performed behind the shielded drawing station. 5. The dose is withdrawn into a lucite shielded syringe or equivalent wearing 2 pair of disposable gloves and a ring badge. 6. The dose is assayed in the dose calibrator and placed in a lead shielded transport box. The Radiopharmacy Label identifying the product, quantity and calibration date is affixed to the box. PATIENT PREP 1. The nuclear medicine physician confirms female patients are not pregnant when appropriate. 2. The nuclear medicine physician or radiation oncologist obtains the informed consent from the patient. 3. Immediately before administration, the patient is hydrated with approximately 500mL of normal saline. 4. Clinical staff will ascertain whether the patient is continent. If the patient is incontinent, precautions will be explained. A Health Facts for You for Quadramet (Samarium Sm- 153 Lexidronam Injection) will distributed to the patient. PREPARATION OF INPATIENT TREATMENT ROOM: 1. Patients receiving therapeutic doses are usually admitted to a radiotherapy room on[ INSERT APPROPRIATE LOCATION HERE for example, C ] These rooms have radioactive warning signs that must be overturned once the patient has received their treatment. However, there are times when these rooms are not available, and the patients have to be admitted to a non- radiotherapy room. If this is the case, a radioactive warning sign must be hung on the outside of the patient s door. 2. Tape absorbent pads with waterproof backing to the floor along the sides of the toilet to absorb potential urine contamination. 4
5 3. Ensure the special waste receptacle labeled [ENTER APPROPRIATE LABLE for example Nuclear Medicine ] is moved to the treatment room. The container must be lined with two large plastic bags obtained in the same room. 4. Ensure the entrance door to the room has a Radiation Warning Sign. 5. Ensure absorbent pads are available to place on the floor under the IV pole stand and under the patient s arm with the infusion site. 6. If the patient is treated as an inpatient, the patient s room is prepared according to the protocol for high dose I 131 treatments. (see I 131 treatment protocol). 7. The patient s treatment room must be decommissioned once the patient is discharged. ADMINISTRATION OF THERAPY: 1. The prescribed dose of Sm- 153 will be administered intravenously using a peripheral IV or central line. This will usually be performed as an outpatient. **Peripheral IV administration is typically used 2. Injection is through the existing IV line. An initial test injection is first administered, comprising of about 0.1mL of the dose. 3. Following the test injection, the Administering Clinician will survey the patient s chest with a GM meter on the surface above the heart, to confirm activity has been carried from the injection site through the circulatory system. 4. Following positive indications of patency of the IV line, the remaining solution is injected via IV push over approximately 2 minutes. 5. Following the injection, an additional 250 ml of normal saline is run through the IV line. 6. The Clinician removes the IV line. **When administering a high dose of Quadramet the following should be done: High dose Sm- 153 should be administered systemically through a central line using an infusion syringe pump. The syringe pump should be shielded with lucite and lead to reduce radiation exposure to the staff. The typical infusion time will be 30 mins. 7. Absorbent plastic lined pads should be placed under the infusion pump and work area to contain any contamination. 8. The nuclear medicine physician administering the dose must wear disposable double gloves, lab coat, TLD, and ring badge. 9. The empty dose syringe is placed in the lead container for transport to[insert APPROPRIATE NAME OF WASTE CONTAINER for example Nuclear Medicine. ] All other materials used in the administration of the Sm- 153 are to be collected in plastic bags for return to [INSERT APPROPRIATE NAME OF WASTE CONTAINER for example Nuclear Medicine] for monitoring and storage for decay as necessary. DOSE MEASUREMENTS 1. Dose measurements are to be recorded with a the Victoreen or Fluke dose rate survey meter at a distance of 1 meter from the patient. The measurements are to be taken and recorded as to time and date following administration of the therapy dose and daily and prior to discharge of the patient from the hospital. 5
6 2. Calibrate the Victoreen or Fluke prior to each measurement. [INSERT APPROPRIATE NAME if other methods or equipment are used.] 3. The radiation dose measurements are recorded with the patient standing and facing the survey meter. The meter distance is measured from the center of the patient. The center of the patient means mid height and mid width point. The height of the survey meter should be in line with the central point and at 1 meter from the patient to the calibration line on the cutie pie. 4. A background measurement is made in an area remote from any radioactivity. This background measurement is subtracted from the dose measured. 5. If an inpatient, all of the radiation dose measurements are recorded on the Instructions For Nursing of Patients Who Have Received Radionuclide Therapy form in the patient s chart, on the decommissioning form and on the requisition for post therapy scan. The formula is as follows: GBq in patient= Dose given (GBq x reading of patient at time x) msv/hr reading of patient at time (15 minutes) msv/hr) 6. Record the patient s dose rate at 15 minutes and at discharge. 7. The nuclear medicine physician will authorize the discharge of the patient. 8. After patient discharge, the RSOs delegate (nuclear medicine technologist on duty or on call) shall conduct a final survey of the room. DISCHARGE PROTOCOL NOTE: If a patient s residual radioactivity reading at the time of discharge is greater than 5, 200 MBq, The physician must fill out and give to the patient a copy of Authorization for the release of Patients with doses exceeding 1.1 GBq form AND a completed copy of Instructions for Out Patient Following Treatment with a radioactive material form. After patient discharge, the RSO's delegate (Nuclear Medicine technologist on duty or on- call) shall conduct a final survey of the room. The following steps will be taken to decommission a patient treatment room: 1. A Decommissioning Patient Treatment Room worksheet must be filled out for every patient and the worksheet record is retained by Nuclear Medicine. 2. Using the [Berthold] contamination survey meter, the following areas must be monitored: a) background b) phone c) door handle d) bed e) floor around bed f) faucet handles 6
7 g) toilet seat h) TV controls i) absorbent pads at the base of toilet j) personal waste & disposables k) other 3. The allowable limits on the CNSC licence are: a) Removable contamination: 3.0 Bq/cm2 averaged over an area 100 cm2 using Berthold contamination monitor (3,000 counts per minute at surface using pancake contamination monitor). b) Fixed contamination: 0.5 μsv/hr at 0.5 m using the Victoreen or Fluke survey meter c) Linen 2.5 μsv at external surface of laundry container using the Victoreen or Fluke survey meter. 4. If contamination is found, the decontamination supplies on the decommissioning cart, are used by the technologist to decontaminate the area to levels not to exceed the allowable limits as specified in #3 above. 5. Contaminated linen exceeding the limits is moved to the [INSERT APPROPRIATE NAME for example long term radioactive storage room.] 6. The personal waste and disposables collected in the blue receptacle labelled [INSERT APPROPRIATE NAME for example "Nuclear Medicine " ] must be monitored and removed. If the garbage is contaminated, the technologist is to attach a label to the garbage bag identifying the radionuclide and date, and to wheel the receptacle to the long- term radioactive storage room. The receptacle is to be left in the soiled utility room [SPECIFY LOCATION. For example, on level 1, between the C and D zones for cleaning (housekeeping will return it to C71 once cleaned).] If the garbage is not contaminated, the Nuclear Medicine technologist is responsible for transporting the "Nuclear Medicine" waste receptacle from the patient's room to the soiled utility room [SPECIFY LOCATION. For example on level 1, between the C and D zones. ] The plastic bag of garbage is to be left in the room per arrangement with Housekeeping. 7. If the technologist encounters any problem, i.e. cannot decontaminate the room within allowable limits, the RSO or his/her delegate is to be notified. If this occurs on the weekend, the room is to remain closed until the RSO or his/her delegate is available to act on it Monday morning. The RSO or delegate will then decide the next step of action to be taken. The technologist is not responsible for ordering room closures. 8. The personal waste in the long- term radioactive storage room is to be monitored on a consistent basis after the treatment so that once it has decayed to background levels, it can be sent for disposal in order to avoid the creation of bad odours, etc. in the room. Once the waste can be discarded, remove radioactive waste label and call Housekeeping to remove waste from the storage area. 7
8 OUTPATIENT TREATMENT AND RELEASE Criteria for Selection of Patients for Out- patient Treatment with Sm- 153 EDTMP: 1. The patient must, in the opinion of the physician, be able to follow the instructions and be likely to comply with them. 2. The patient does not require hospitalization for medical reasons. 3. The patient must confirm that separate sleeping arrangements are possible for the recommended time. 4. If there are small children or pregnant women in the home, contact should deliver an estimated dose of no more than 1 msv to them. 5. The dose calculation will be based on Regulatory Guide Release of Patients Administered Radioactive Materials, US Nuclear Regulatory Commission, April Ideally there should be more than one bathroom in the house and one of them designated for the exclusive use of the patient. 7. Care provided by family members shall be provided by non- pregnant adults who undertake to give the support knowingly and willingly. The situation regarding radiation exposure will be described to the provider with instructions regarding time, proximity and cumulative dosage. 8. An estimated dose of up to 5 msv is permissible without badging or bioassaying the care provider. The dose calculation will be based on Regulatory Guide Release of Patients Administered Radioactive Materials, US Nuclear Regulatory Commission, April INSTRUCTIONS/GUIDELINES FOR THE PATIENTS: 1. Male patients must sit on the toilet to void/urinate/empty bladder. 2. Flush the toilet twice after use. 3. Wash hands with soap and plenty of water every time after using the toilet and rinse the sink. 4. Visitors restricted for 30 minute visits to a maximum of three times per day while maintaining a minimal distance of 1 meter from the patient. Children and pregnant females are not permitted to visit. 5. Dose readings: The patient will be monitored after administration of the therapy dose and each day thereafter until discharge. 6. Explain that absorbent pads with waterproof backing will be taped to the floor along the sides of the toilet to absorb potential urine contamination. 7. There will be a special waste container in the room where all disposable items and personal waste are to be placed. Drink containers should be emptied into the sink before placing in the waste container. 8. Inform the patient that the nursing staff are aware of all radiation precautions. 9. Assure the patient that if he/she runs into any problems, there are nuclear medicine staff available and on call to provide answers. 8
Radiation Sciences Nuclear Medicine Technology Program Hot Lab Log Book (Material)
Radiation Sciences Nuclear Medicine Technology Program Hot Lab Log Book (Material) Table of Content Receiving a Radioactive Package Constancy Test Daily Survey Weekly Wipes Accuracy Test Linearity Geometric
More informationRadiopharmaceuticals that can be used for alleviating pain caused by bone metastases:
Methodological letter of Nuclear Medicine Professional College and Radiotherapy and Oncology Professional College on the treatment of bone metastases with open radioactive isotopes Bone metastases of tumours
More informationHigh Dose Radioactive Iodine (I-131) Therapy for Treatment of Thyroid Cancer
12 High Dose Radioactive Iodine (I-131) Therapy for Treatment of Thyroid Cancer Please arrive 15 minutes early to allow for parking and registration. If you have questions or need to cancel your appointment
More informationSafe Handling of Cytotoxic Materials
Safe Handling of Cytotoxic Materials Kara Henman RN, MN, CON(C) Oncology Practice Consultant Cancer Care Nova Scotia What are hazardous drugs? Chemotherapy Immunosuppressive agents Biological agents Antiviral
More informationIn-Patient Radioactive Iodine ( 131 I) Treatment
In-Patient Radioactive Iodine ( 131 I) Treatment Information for patients and families Princess Margaret Read this booklet to learn: what radioactive iodine treatment is what to expect instructions to
More informationTEMPLE UNIVERSITY ENVIRONMENTAL HEALTH AND RADIATION SAFETY
Page 1 of 7 ISSUED: 5/00 REVISED: 08/06 1. Potential Releases of Radioactive Materials to Unrestricted Areas The Environmental Health and Safety Department (EHRS) must be notified immediately if an emergency
More informationCYTOTOXIC PRECAUTIONS A GUIDE FOR PATIENTS & FAMILIES
Perth and Smiths Falls District Hospital Attention: Manager, Quality 60 Cornelia Street, West Smiths Falls, Ontario K7A 2H9 CYTOTOXIC PRECAUTIONS A GUIDE FOR PATIENTS & FAMILIES This guide has been prepared
More informationUTCVM PHARMACY STANDARD OPERATING PROCEDURES
UTCVM PHARMACY STANDARD OPERATING PROCEDURES Updated: 4/5/2004 I. General Procedures A. Hours: The Pharmacy will be open Monday through Friday, 8:00AM to 6:00PM; Saturday 8:00AM to 1:00PM. The Pharmacy
More informationReceiving Radioactive Iodine for Thyroid Cancer
Patient Education Receiving Radioactive Iodine for Thyroid Cancer Information, instructions, and precautions This handout gives instructions for patients who will receive radioactive iodine as part of
More informationHazardous Precautions. Prepared By: Hazardous Precautions Working Group Updated: March 2014
Hazardous Precautions Prepared By: Hazardous Precautions Working Group Updated: March 2014 1 What are Hazardous Medications? They are therapeutic agents that are often used in the treatment of: cancer,
More informationGUIDELINES FOR NUCLEAR PHARMACY TECHNICIAN TRAINING PROGRAMS
GUIDELINES FOR NUCLEAR PHARMACY TECHNICIAN TRAINING PROGRAMS Prepared by Ad Hoc Committee on Nuclear Pharmacy Technicians Nuclear Pharmacy Section Academy of Pharmacy Practice and Management American Pharmaceutical
More informationSAFE HANDLING OF HAZARDOUS MEDICATIONS. Cytotoxic and Non-Cytotoxic. Winnipeg Regional Health Authority Policy # 110.160.010
SAFE HANDLING OF HAZARDOUS MEDICATIONS Cytotoxic and Non-Cytotoxic Winnipeg Regional Health Authority Policy # 110.160.010 By the end of this presentation staff should be able to 1. Understand what information
More informationPatient Guide to Radioactive Iodine Treatment
PATIENT EDUCATION patienteducation.osumc.edu Patient Guide to Radioactive Iodine Treatment What is the Thyroid Gland? The thyroid is a small butterfly-shaped gland in the neck. Your thyroid gland makes
More informationINSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section:
HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER HANDLING OF H AZARDOUS DRUGS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES APPROVED
More informationTo provide direction for the safe handling, administration and disposal of hazardous drugs.
Subsection: MEDICATION Related terms: Cytotoxic Drugs, Antineoplastic Drugs Authorized by: Clinical Directors CS-04-02-01 Page 1 of 9 Date Established: October 2006 Date For Review: September 2014 Dates
More informationRadiology Services Policies and Procedures
Radiology Services Policies and Procedures November 2011 Table of Contents - Alphabetical Please Note! Clicking on a title in the Table of Contents will take you to that document. To find a particular
More informationPositron Emission Tomography - For Patients
Positron Emission Tomography - For Patients A physician s written order is required for any PET-CT tests. How should I prepare for my PET-CT? PET-CT is more complicated than most other tests you may be
More informationRadiation Safety for Nurses
Medical Care Program Southern California Region Radiation Safety for Nurses Rev. 2/01 Nursing RADIATION SAFETY FOR NURSES HOW TO USE THIS HANDOUT This handout is in two parts, and you should use each part
More informationDeveloping an Institutional 131. I MIBG Therapy Program
Developing an Institutional 131 I MIBG Therapy Program Frederic H. Fahey DSc Boston Children s Hospital Harvard Medical School frederic.fahey@childrens.harvard.edu Thanks to S. Ted Treves, Fred Grant,
More informationCytotoxic Agents Safe Management For Nursing Students. Pat Stalker Clinical Educator, LRCP Feb 2015
Cytotoxic Agents Safe Management For Nursing Students Pat Stalker Clinical Educator, LRCP Feb 2015 Overview and Objectives Review key content of the nursing procedure Differentiate between Hazardous drugs
More informationIodine-131 Treatment of Thyroid Cancer Information about your treatment November 2011 Great Staff Great Care Great Future
Department of Nuclear Medicine Iodine-131 Treatment of Thyroid Cancer Information about your treatment November 2011 Great Staff Great Care Great Future INTRODUCTION This leaflet has been produced to give
More informationUW MEDICINE PATIENT EDUCATION. Xofigo Therapy. For metastatic prostate cancer. What is Xofigo? How does it work?
UW MEDICINE PATIENT EDUCATION Xofigo Therapy For metastatic prostate cancer This handout explains how the drug Xofigo is used to treat metastatic prostate cancer. What is Xofigo? Xofigo is a radioactive
More informationRadioactive Ra 223 therapy. Information for patients Weston Park Hospital
Radioactive Ra 223 therapy Information for patients Weston Park Hospital page 2 of 8 This leaflet contains information about radioactive Ra 223 therapy. If you have any questions about your treatment,
More informationSpillage Waste Management
Spillage Waste Management Patient Information Introduction This leaflet contains the answers to some questions patients and carers may have about the disposal of chemotherapy waste and the management of
More informationURINARY CATHETER INSERTION - STRAIGHT OR INDWELLING CATHETER
URINARY CATHETER INSERTION - STRAIGHT OR INDWELLING CATHETER PURPOSE To obtain a sterile urine specimen. To facilitate emptying bladder. To relieve bladder distention. To irrigate bladder. To measure residual
More informationRadium-223 Therapy: Handling & Radiation Safety Issues
Nuclear Physics Enterprises Radium-223 Therapy: Handling & Radiation Safety Issues Jeffry A. Siegel, Ph.D. President & CEO 2014 Meeting Mid-Atlantic States Radiation Control Programs Malvern, PA NRC s
More informationEmergencies Involving Radiation
Page 1-1 Section 1 Emergencies Involving Radiation Contents A. Emergency Phone Numbers...1-2 1. Campus... 1-2 a. Radiation Safety Office 543-0463... 1-2 b. University Police 9-911... 1-2 2. Off Campus...
More informationGuidelines for the Management of Spillage of Cytotoxic Drugs. No changes have been made as evidence base remains current.
Guidelines for the Management of Spillage of Cytotoxic Drugs Date Approved by Network Governance May 2012 Date for Review May 2015 Changes Between Versions 3.0 and 4.0 No changes have been made as evidence
More informationMedications or therapeutic solutions may be injected directly into the bloodstream
Intravenous Therapy Medications or therapeutic solutions may be injected directly into the bloodstream for immediate circulation and use by the body. State practice acts designate which health care professionals
More informationSurface Contamination in Skin and Room during Hospitalization of Thyroid Cancer Patient Receiving Radioiodine Ablation
IOSR Journal of Dental and Medical Sciences (JDMS) ISSN: 2279-0853, ISBN: 2279-0861. Volume 2, Issue 1 (Sep-Oct. 2012), PP 27-33 Surface Contamination in Skin and Room during Hospitalization of Thyroid
More informationSafe Disposal Methods Management of Body Substances from Patients Undergoing and Following Cytotoxic Drug Therapy Background Hospital/ Institution Home Physician Nurse Nurse Aide Personnel handling waste
More informationSpills of Radioactive Materials - Emergency Procedures
A. Purpose When a spill occurs, efforts should be directed at minimizing personnel exposure and contamination and containing spread of contamination. When spills are associated with other events such as
More informationChemotherapy Spill Response:
Chemotherapy Spill Response: Antineoplastic Spills Outside Of A Fume Hood Lisa Hudley, RN Training Coordinator Safety & Environmental Compliance William Guess Director Safety & Environmental Compliance
More informationRADIOACTIVE WASTE MANAGEMENT PLAN
RADIOACTIVE WASTE MANAGEMENT PLAN Copies of this plan will be made available to all members of the campus community with the potential to generate radioactive waste. Contents I. Purpose II. Regulatory
More informationBrachytherapy: Low Dose Rate (LDR) Radiation Interstitial Implant
Brachytherapy: Low Dose Rate (LDR) Radiation Interstitial Implant Goal of the Procedure Brachytherapy, or internal radiation therapy, is a way of giving a higher dose of radiation to the tumor area while
More informationPERSONNEL MONITORING AND DOSIMETRY POLICIES
PERSONNEL MONITORING AND DOSIMETRY POLICIES All individuals who are required to have their exposure to ionizing radiation monitored must be trained prior to using the source(s) of radiation. The radioactive
More informationCytotoxic Precautions at Home A Guide for Cancer Patients and Families
Cytotoxic Precautions at Home A Guide for Cancer Patients and Families Your cancer treatment... 1 What are cytotoxic precautions?... 1 What body fluids are cytotoxic?... 1 How do I handle my body wastes?...
More informationPHARMACEUTICAL WASTE MANAGEMENT DUKE UNIVERSITY HEALTH SYSTEM
PHARMACEUTICAL WASTE MANAGEMENT DUKE UNIVERSITY HEALTH SYSTEM BLUE BIN DRUGS ONLY NO EMPTY Packages, NO Gloves NO Scissors, Syringes, Needles, IVs Scalpels, Forceps BLUE BIN PROGRAM PURPOSE AND OBJECTIVE:
More informationGUIDE FOR THE PREPARATION OF RADIOACTIVE MATERIAL APPLICATIONS FOR WELL LOGGING OPERATIONS IN KENTUCKY
GUIDE FOR THE PREPARATION OF RADIOACTIVE MATERIAL APPLICATIONS FOR WELL LOGGING OPERATIONS IN KENTUCKY Radiation Control Cabinet for Human Resources 275 East Main Street Frankfort, Kentucky 40621 JANUARY
More informationUW School of Dentistry Comprehensive Medication Policy
UNIVERSITY OF WASHINGTON SCHOOL OF DENTISTRY Subject: UW School of Dentistry Comprehensive Medication Policy Policy Number: Effective Date: December 2014 Revision Dates: June 2015 PURPOSE This policy provides
More informationComparison of Medical and DOE Health Physics Programs. Kevin Lee Radiation Safety Officer Palmetto Health
Comparison of Medical and DOE Health Physics Programs Kevin Lee Radiation Safety Officer Palmetto Health Objectives To understand basic medical use of radiation producing equipment and radioactive materials.
More informationAmbulatory Surgical Centers Frequently Asked Questions
Ambulatory Surgical Centers Frequently Asked Questions Index Top General Definitions Compliance with State Licensure Laws Governing Body and Management Surgical Services Quality Assessment and Performance
More informationHAZMAT Employee Training D.O.T. Radioactive Material Shipments #8 (02/12)
HAZMAT Employee Training D.O.T. Radioactive Material Shipments #8 (02/12) HAZMAT EMPLOYEE: TRAINING DATE: 1. Hazardous Materials Regulations (HMR) originate from the following government agency: a. U.S.
More informationSOP #: Revision #: Current Version Implementation Date: Page #: Page 1 of 10 Last Reviewed/Update Date: Expiration
Implementation Page #: Page 1 of 10 Last Reviewed/Update 1. Purpose and Scope The purpose of this document is to describe the Medical Physics and Radiation Safety program at Boston University (BU) and
More informationThe following assumptions are to be considered when reviewing this model procedure:
Transportation Emergency Preparedness Program (TEPP) Model Procedure for Properly Handling and Packaging Potentially Radiologically Contaminated Patients This Transportation Emergency Preparedness Program
More informationARKANSAS. Downloaded January 2011
ARKANSAS Downloaded January 2011 302 GENERAL ADMINISTRATION 302.11 Pharmacies operated in nursing homes shall be operated in compliance with Arkansas laws and shall be subject to inspection by personnel
More informationPolicies & Procedures. ID Number: 1118
Policies & Procedures Title: INTRAVENOUS AND/OR PERIPHERAL SALINE LOCK INSERTION AND MAINTENANCE ID Number: 1118 Authorization [X] SHR Nursing Practice Committee Source: Nursing Date Revised: September
More informationStandard Operating Procedure for Dacarbazine in Animals
Standard Operating Procedure for Dacarbazine in Animals 1. Health hazards Dacarbazine, also known as DTIC, DIC, and Imidazole Carboxamide, is an antineoplastic chemotherapy drug used in the treatment of
More informationIX. EMERGENCY PLANNING
IX. EMERGENCY PLANNING EMERGENCY PLANNING, SPILL RESPONSE & REPORTING Any unexpected event or accident situation that occurs during the transport, storage or use of hazardous materials constitutes a potential
More informationPerformance-Based Inspection Field Guide
Non-radioactive material worker Performance-Based Inspection Field Guide 1. Have you completed the on-line Radiation Safety Course? If yes, get the individual s name.# to verify attendance If no, instruct
More informationINTERDISCIPLINARY CLINICAL MANUAL Policy and Procedure
INTERDISCIPLINARY CLINICAL MANUAL Policy and Procedure TITLE: Safe Handling of Cytotoxic Drugs/Waste NUMBER: CC 05-055 Date Issued: August 2011 Page 1 of 11 Applies To: Holders of Interdisciplinary Clinical
More informationEMERGENCY PROCEDURES FOR RADIOACTIVE MATERIAL. 2. Prevent the spread of contamination by covering the spill with absorbent paper.
EMERGENCY PROCEDURES FOR RADIOACTIVE MATERIAL MINOR SPILLS: 1. Notify persons in the area that a spill has occurred. 2. Prevent the spread of contamination by covering the spill with absorbent paper. 3.
More informationDisposal of Pharmaceuticals, and their empty containers, in the Workplace
Disposal of Pharmaceuticals, and their empty containers, in the Workplace Prepared by Bio-Team Mobile LLC There is a lot of misinformation being circulated about disposal of pharmaceuticals ever since
More informationNorwalk-Like Viruses Decontamination Guidelines for Environmental Services
Norwalk-Like Viruses Decontamination Guidelines for Environmental Services This document has been developed in accordance with current applicable infection control and regulatory guidelines. It is intended
More informationRecommendations for the Safe Use of Handling of Cytotoxic Drugs
Recommendations for the Safe Use of Handling of Cytotoxic Drugs Introduction Cytotoxic drugs are toxic compounds and are known to have carcinogenic, mutagenic and/or teratogenic potential. With direct
More informationMEDICAL/CERTIFIED MEDICAL ASSISTANT
MEDICAL/CERTIFIED MEDICAL ASSISTANT Occ. Work Prob. Effective Last Code No. Class Title Area Area Period Date Action 4547 Medical Assistant 12 442 6 mo. 07/15/12 Rev. 0000 Certified Medical Assistant 12
More informationFact Sheet. Caring for and Changing your Supra-Pubic Catheter (SPC) Queensland Spinal Cord Injuries Service
and Caring for and Changing your Supra-Pubic Catheter (SPC) What is a Suprapubic Catheter? A supra-pubic catheter is a tube that goes into your bladder through your abdominal wall which continuously drains
More informationThyroid Cancer Finding It and Treating It Using Radioiodine
Thyroid Cancer Finding It and Treating It Using Radioiodine Your doctor has referred you to Nuclear Medicine to learn more about the extent of your thyroid cancer, and perhaps even for treatment of the
More informationDarren Lackan, MD Chris Bajaj, DO Anjanette Tan, MD Christopher Hudak, MD
Darren Lackan, MD Chris Bajaj, DO Anjanette Tan, MD Christopher Hudak, MD I-131 (Radioactive Iodine) Treatment Patient Name: : Out of courtesy, our office expects 24 hour notice for the cancellation of
More informationBlood sampling and transportation Standard Operating Procedure
Blood sampling and transportation Standard Operating Procedure 1. Rationale for test 2. Requirements 3. Equipment 4. Method for blood taking 5. Instructions for Safe Box and transportation of samples 6.
More informationBOSTON COLLEGE ENVIRONMENTAL HEALTH AND SAFETY LABORATORY GUIDE FOR RENOVATIONS, REMODELS, MOVES AND TERMINATIONS
BOSTON COLLEGE ENVIRONMENTAL HEALTH AND SAFETY LABORATORY GUIDE FOR RENOVATIONS, REMODELS, MOVES AND TERMINATIONS I. Policy for Termination of Laboratory Use of Hazardous Materials The Principal Investigator
More informationI-140 Venipuncture for Blood Specimen Collection
I-140 Venipuncture for Blood Specimen Collection Purpose Obtain a blood specimen by venipuncture for laboratory analysis using aseptic technique. Applies To Registered Nurses Licensed Practical/Vocational
More informationCapital District Health Authority Radiation Safety Office
Capital District Health Authority Radiation Safety Office Radiation Safety for Security Services HOUSEKEEPING SERVICES Presentation Code 22.2 1 Introduction The following presentation... Provides department
More informationMANITOBA PATIENT SERVICE CENTRE STANDARDS
MANITOBA PATIENT SERVICE CENTRE STANDARDS February 2015 INTRODUCTION These Standards are derived from Z316.7-12 and are approved by the Council of the College of Physicians and Surgeons of Manitoba. These
More informationCytotoxic and Biotherapies Credentialing Programme Module 6
Cytotoxic and Biotherapies Credentialing Programme Module 6 1. Safe Handling and Administration of Cytotoxic and Biotherapies 2. Waste and Spill Management At the completion of this module the RN will
More informationPolicy and Procedure Flushing and / or Blood withdrawal Aspiration Procedure For PICC Line and Midline Catheters
Policy and Procedure Flushing and / or Blood withdrawal Aspiration Procedure For PICC Line and Midline Catheters Purpose: Blood Withdrawal: To obtain blood samples for laboratory evaluation, eliminating
More information2.3. The management in each HCF shall be responsible for ensuring good waste management practices in their premises.
1. PURPOSE Health-care activities lead to production of medical waste that may lead to adverse health effects. Most of this waste is not more dangerous than regular household waste. However, some types
More informationElectronic Medication Administration Record (emar) (For Cerner Sites Only)
POLICY NO. 1009 Approved: 12/05 Effective: 12/05 Reviewed: 9/10; 5/12 1. Purpose: Electronic Medication Administration Record (emar) (For Cerner Sites Only) To provide direction for the transcription and
More informationPATIENT GUIDE. Understand and care for your peripherally inserted central venous catheter (PICC). MEDICAL
PATIENT GUIDE Understand and care for your peripherally inserted central venous catheter (PICC). MEDICAL Introduction The following information is presented as a guideline for your reference. The best
More informationCOMMUNITY HOSPITAL REGISTERED NURSE PRINTED NAME:
COMMUNITY HOSPITAL REGISTERED NURSE EMPLOYEE: PRINTED NAME: REPORTS TO: DEPARTMENT: FMLA STATUS: Date: Director of Med-Surg Nursing Non-exempt PURPOSE: The Registered Nurse is responsible for the ongoing
More informationSafe Handling of Hazardous Drugs
Safe Handling of Hazardous Drugs Staff Education May 1, 2015 Safe Handling of Hazardous Drugs Most hospitals have policies & procedures for the handling of cytotoxic drugs (chemotherapy) But what about
More informationCONNECTICUT. Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION
CONNECTICUT Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION (d) General Conditions. (6) All medications shall be administered only by licensed
More informationMedical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11
Effective Date: 09/12/06, 08/02/10, 3/2/11 Title: 1.0 OBJECTIVE: 1.1 This SOP describes the methods and policies for: Handling investigational drug Dispensing investigational drug 1.2. This procedure applies
More informationSTATE OF NEW YORK DEPARTMENT OF HEALTH
STATE OF NEW YORK DEPARTMENT OF HEALTH Flanigan Square, 547 River Street, Troy, New York 12180-2216 Antonia C. Novello, M.D., M.P.H., Dr.P.H. Commissioner Dennis P. Whalen Executive Deputy Commissioner
More informationWard 29 guide to the safe preparation and administration of intravenous (IV) antibiotics at home
Ward 29 guide to the safe preparation and administration of intravenous (IV) antibiotics at home Contents Page Important contact numbers 1 General information on preparing and administering IV antibiotics
More informationhttp://www.bls.gov/oco/ocos104.htm
http://www.bls.gov/oco/ocos104.htm Nuclear Medicine Technologists Nature of the Work Training, Other Qualifications, and Advancement Employment Job Outlook Projections Data Earnings OES Data Related Occupations
More informationPOLICY AND PROCEDURES FOR PROVIDING NARCOTIC ADDICTION TREATMENT TO PREGNANT OPIOID DEPENDENT INMATES INCARCERATED IN THE COUNTY JAIL
PURPOSE POLICY AND PROCEDURES FOR PROVIDING NARCOTIC ADDICTION TREATMENT TO PREGNANT OPIOID DEPENDENT INMATES INCARCERATED IN THE COUNTY JAIL To outline the procedures used in recognizing and providing
More informationBiosafety Spill Response Guide
Yale University Office of Environmental Health & Safety Biosafety Spill Response Guide Office of Environmental Health & Safety 135 College Street, 1 st Floor, New Haven, CT 06510 Telephone: 203-785-3550
More informationPolicies. Prep Room Policies
Introduction INTRODUCTION The Microbiology Prep Room is located in 531A Life Sciences Building. The telephone number is 372-8609. It is open from 7:30 a.m. to 4:30 p.m. during the fall and spring semesters.
More informationInfectious Waste Management Plan
Infectious Waste Management Plan Infectious Waste Management Plan USC Health & Safety Programs Unit 777-5269 POLICY: A. In keeping with the University of South Carolina's policy of providing protection
More informationINSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES
HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER MEDICATIONS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES APPROVED BY APPLIES
More informationTHYROGEN-STIMULATED RADIOACTIVE IODINE (I-131) THERAPY FOR THYROID CANCER FOLLOWED BY WHOLE BODY SCAN
MANFRED BLUM, M.D. F.A.C.P. NYU School of Medicine 530 First Avenue New York, N.Y. 10016 OFFICE:Phone (212) 263-7444 Fax (212) 263-0401 LAB: Phone (212) 263-7410 Fax: (212) 263-7519 Rev.7/1/09 FORM 4B
More informationBOARD OF PHARMACY DIVISION 41 OPERATION OF PHARMACIES (RETAIL AND INSTITUTIONAL DRUG OUTLETS) CONSULTING PHARMACISTS AND OPERATION OF DRUG ROOMS
BOARD OF PHARMACY DIVISION 41 OPERATION OF PHARMACIES (RETAIL AND INSTITUTIONAL DRUG OUTLETS) CONSULTING PHARMACISTS AND OPERATION OF DRUG ROOMS 855-041-6050 Definitions Hospitals with Pharmacies (1) In
More informationNuclear medicine. Answering your questions
Nuclear medicine Answering your questions ANSTO s OPAL research reactor in Sydney What is nuclear medicine? This is a branch of medicine that uses radiation from radioactive tracers to provide information
More informationSociety of Nuclear Medicine 1850 Samuel Morse Drive Reston, VA 20190-5316 www.snm.org
What is nuclear medicine? Nuclear medicine is a medical specialty that is used to diagnose and treat diseases in a safe and painless way. Nuclear medicine procedures permit the determination of medical
More informationQuality Assurance Testing of AtomLab Dose Calibrators
(Manufacturer s* Instructions) Introduction The following procedures are the manufacturer s instructions for qualifying AtomLab 100, 100+, 200, 300, 400, and 500 dose calibrators in accordance with NRC
More informationPrepared for the Department of Energy Office of Transportation and Emergency Management. 02B00215-13.p65
TEPP Planning Products e for Medical Examiner/Cor on the Handling of a Body/Human Remains that are Potentially Radiologically Contaminated 02B00215-13.p65 Prepared for the Department of Energy Office of
More informationREGIONAL. Applicable to all sites and facilities where the intended WRHA program services are delivered
REGIONAL Applicable to all sites and facilities where the intended WRHA program services are delivered Level: 1A Policy Name: Cytotoxic Agents, Safe Handling of Approval Signature: Policy Number: Section:
More informationIII-701 Urinary Catheterization/Bladder Irrigation Original Date: 3/1/1977 Last Review Date: 10/28/2004
III-701 Urinary Catheterization/Bladder Irrigation Original Date: 3/1/1977 Last Review Date: 10/28/2004 Purpose A. Allow for precise measurement of urine output. B. Collect a sterile urine specimen. C.
More informationDEPARTMENT OF HEALTH PO BOX 358 TRENTON, N.J. 08625-0358. www.nj.gov/health
CHRIS CHRISTIE Governor KIM GUADAGNO Lt. Governor Dear Administrator: DEPARTMENT OF HEALTH PO BOX 358 TRENTON, N.J. 08625-0358 www.nj.gov/health January, 2013 MARY E. O DOWD, M.P.H. Commissioner Since
More informationAdministration of Medications & Fluids via a Peripheral Intravenous Cannula
Administration of Medications & Fluids via a Peripheral Intravenous Cannula Clinical S.O.P. No.: 22.0 Compiled by: Approved by: Review date: November 2016 Administration of Medications & Fluids via S.O.P.
More informationInpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.
Inpatient Anticoagulation Safety Purpose: Policy: To provide safe and effective anticoagulation therapy through a collaborative approach. Upon the written order of a physician, Heparin, Low Molecular Weight
More informationSUBCHAPTER 24 - NUCLEAR MEDICINE TECHNOLOGY
SUBCHAPTER 24 - NUCLEAR MEDICINE TECHNOLOGY 7:28-24.1 Purpose, scope and applicability (a) This subchapter establishes educational and licensure requirements, as well as delineating the scope of practice
More informationRadioactive iodine treatment for thyroid cancer
Radioactive iodine treatment for thyroid cancer This information is an extract from the booklet, Understanding thyroid cancer. You may find the full booklet helpful. We can send you a copy free see page
More informationHumulin R (U500) insulin: Prescribing Guidance
Leeds Humulin R (U500) insulin: Prescribing Guidance Amber Drug Level 2 We have started your patient on Humulin R (U500) insulin for the treatment of diabetic patients with marked insulin resistance requiring
More informationTHE DISPOSAL OF HEALTHCARE WASTE BY NHS GRAMPIAN FROM ACUTE HOSPITAL WARDS
THE DISPOSAL OF HEALTHCARE WASTE BY NHS GRAMPIAN FROM ACUTE HOSPITAL WARDS Arrangements for the Collection and Disposal of Healthcare Waste NHS Grampian provides a range of healthcare waste disposal services
More informationCytotoxic and Biotherapies Credentialing Programme Module 5
Cytotoxic and Biotherapies Credentialing Programme Module 5 1. Drug Dose Determination 2. Drug Calculations 3. Role of the Second Checker 4. The Checking Process At the completion of this module the RN
More informationUnderstanding Quadramet
Understanding Quadramet International Myeloma Foundation 12650 Riverside Drive, Suite 206 North Hollywood, CA 91607 USA Telephone: 800-452-CURE (2873) (USA & Canada) 818-487-7455 Fax: 818-487-7454 TheIMF@myeloma.org
More informationCUESTA COLLEGE REGISTERED NURSING PROGRAM CRITICAL ELEMENTS
CUESTA COLLEGE REGISTERED NURSING PROGRAM CRITICAL ELEMENTS LEVELS I through IV A. OVERRIDING CRITICAL ELEMENTS Violation of an overriding area will result in termination and failure of the particular
More informationUniversity College Hospital. Prostate high dose rate (HDR) brachytherapy. Radiotherapy Department Patient information series
University College Hospital Prostate high dose rate (HDR) brachytherapy Radiotherapy Department Patient information series 18 2 If you need a large print, audio or translated copy of the document, please
More information